{
  "trial_id": "NCT00375492",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, duration of type 2 diabetes, HbA1c, Body Mass Index (BMI), current oral antidiabetes agent regimen, baseline body weight, lipid-lowering agent use, history of medication use (e.g., exogenous insulin, thiazolidinedione, alpha-glucosidase inhibitor, Symlin injection, Byetta injection, gastrointestinal motility drugs, weight loss drugs, systemic corticosteroids), lifestyle modification program adherence.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Baseline Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Baseline Body Weight",
          "baseline body weight"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Baseline Cholesterol",
        "Baseline High Density Lipoprotein (HDL) Cholesterol",
        "Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)",
        "Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)",
        "Baseline Low Density Lipoprotein (LDL) Cholesterol",
        "Baseline Triglycerides",
        "Baseline Waist Circumference"
      ],
      "remaining_candidate_features": [
        "race",
        "duration of type 2 diabetes",
        "Body Mass Index (BMI)",
        "current oral antidiabetes agent regimen",
        "lipid-lowering agent use",
        "history of medication use (e.g., exogenous insulin, thiazolidinedione, alpha-glucosidase inhibitor, Symlin injection, Byetta injection, gastrointestinal motility drugs, weight loss drugs, systemic corticosteroids)",
        "lifestyle modification program adherence."
      ]
    },
    "processed-gen-response": "Age, gender, race, duration of type 2 diabetes, HbA1c, Body Mass Index (BMI), current oral antidiabetes agent regimen, baseline body weight, lipid-lowering agent use, history of medication use (e.g., exogenous insulin, thiazolidinedione, alpha-glucosidase inhibitor, Symlin injection, Byetta injection, gastrointestinal motility drugs, weight loss drugs, systemic corticosteroids), lifestyle modification program adherence."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Duration of Diabetes, Current Oral Antidiabetes Agent Regimen, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Baseline Triglycerides",
          "Triglycerides"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Baseline Body Weight",
        "Baseline Cholesterol",
        "Baseline High Density Lipoprotein (HDL) Cholesterol",
        "Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)",
        "Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)",
        "Baseline Low Density Lipoprotein (LDL) Cholesterol",
        "Baseline Waist Circumference"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Duration of Diabetes",
        "Current Oral Antidiabetes Agent Regimen",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, HbA1c, Duration of Diabetes, Current Oral Antidiabetes Agent Regimen, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Diabetes duration, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol, Waist Circumference, Fasting Glucose, Insulin Dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline Body Weight",
          "Body Mass Index"
        ],
        [
          "Baseline Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Baseline High Density Lipoprotein (HDL) Cholesterol",
          "HDL Cholesterol"
        ],
        [
          "Baseline Low Density Lipoprotein (LDL) Cholesterol",
          "LDL Cholesterol"
        ],
        [
          "Baseline Triglycerides",
          "Triglycerides"
        ],
        [
          "Baseline Waist Circumference",
          "Waist Circumference"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Baseline Cholesterol",
        "Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)",
        "Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Fasting Glucose",
        "Insulin Dose"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, HbA1c, Diabetes duration, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol, Waist Circumference, Fasting Glucose, Insulin Dose."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, height, weight, BMI, HbA1c, duration of type 2 diabetes, type of oral antidiabetes agent regimen, systolic and diastolic blood pressure, heart rate, lipid profiles, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Baseline Body Weight",
          "weight"
        ],
        [
          "Baseline Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Baseline Cholesterol",
          "lipid profiles"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Baseline High Density Lipoprotein (HDL) Cholesterol",
        "Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)",
        "Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)",
        "Baseline Low Density Lipoprotein (LDL) Cholesterol",
        "Baseline Triglycerides",
        "Baseline Waist Circumference"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "height",
        "BMI",
        "duration of type 2 diabetes",
        "type of oral antidiabetes agent regimen",
        "systolic and diastolic blood pressure",
        "heart rate",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, height, weight, BMI, HbA1c, duration of type 2 diabetes, type of oral antidiabetes agent regimen, systolic and diastolic blood pressure, heart rate, lipid profiles, smoking status."
  }
}